BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 16896313)

  • 1. Exploring the distinctive biological characteristics of pilocytic and low-grade diffuse astrocytomas using microarray gene expression profiles.
    Rorive S; Maris C; Debeir O; Sandras F; Vidaud M; Bièche I; Salmon I; Decaestecker C
    J Neuropathol Exp Neurol; 2006 Aug; 65(8):794-807. PubMed ID: 16896313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pilocytic astrocytoma of the optic pathway: a tumour deriving from radial glia cells with a specific gene signature.
    Tchoghandjian A; Fernandez C; Colin C; El Ayachi I; Voutsinos-Porche B; Fina F; Scavarda D; Piercecchi-Marti MD; Intagliata D; Ouafik L; Fraslon-Vanhulle C; Figarella-Branger D
    Brain; 2009 Jun; 132(Pt 6):1523-35. PubMed ID: 19336457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tenascin-C expression relates to clinicopathological features in pilocytic and diffuse astrocytomas.
    Maris C; Rorive S; Sandras F; D'Haene N; Sadeghi N; Bièche I; Vidaud M; Decaestecker C; Salmon I
    Neuropathol Appl Neurobiol; 2008 Jun; 34(3):316-29. PubMed ID: 17983425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression-associated genes in astrocytoma identified by novel microarray gene expression data reanalysis.
    MacDonald TJ; Pollack IF; Okada H; Bhattacharya S; Lyons-Weiler J
    Methods Mol Biol; 2007; 377():203-22. PubMed ID: 17634619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis.
    Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL
    Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An identification of stem cell-resembling gene expression profiles in high-grade astrocytomas.
    Yang Y; Qiu Y; Ren W; Gong J; Chen F
    Mol Carcinog; 2008 Nov; 47(11):893-903. PubMed ID: 18395814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrilin-2 expression distinguishes clinically relevant subsets of pilocytic astrocytoma.
    Sharma MK; Watson MA; Lyman M; Perry A; Aldape KD; Deák F; Gutmann DH
    Neurology; 2006 Jan; 66(1):127-30. PubMed ID: 16401863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined molecular analysis of BRAF and IDH1 distinguishes pilocytic astrocytoma from diffuse astrocytoma.
    Korshunov A; Meyer J; Capper D; Christians A; Remke M; Witt H; Pfister S; von Deimling A; Hartmann C
    Acta Neuropathol; 2009 Sep; 118(3):401-5. PubMed ID: 19543740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of ASCL1 and inhibition of Notch signaling pathway characterize progressive astrocytoma.
    Somasundaram K; Reddy SP; Vinnakota K; Britto R; Subbarayan M; Nambiar S; Hebbar A; Samuel C; Shetty M; Sreepathi HK; Santosh V; Hegde AS; Hegde S; Kondaiah P; Rao MR
    Oncogene; 2005 Oct; 24(47):7073-83. PubMed ID: 16103883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of histological markers for malignant glioma by genome-wide expression analysis: dynein, alpha-PIX and sorcin.
    Yokota T; Kouno J; Adachi K; Takahashi H; Teramoto A; Matsumoto K; Sugisaki Y; Onda M; Tsunoda T
    Acta Neuropathol; 2006 Jan; 111(1):29-38. PubMed ID: 16320026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of immune defense genes in pilocytic astrocytomas.
    Huang H; Hara A; Homma T; Yonekawa Y; Ohgaki H
    J Neuropathol Exp Neurol; 2005 Oct; 64(10):891-901. PubMed ID: 16215461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling and subgroup identification of oligodendrogliomas.
    Huang H; Okamoto Y; Yokoo H; Heppner FL; Vital A; Fevre-Montange M; Jouvet A; Yonekawa Y; Lazaridis EN; Kleihues P; Ohgaki H
    Oncogene; 2004 Aug; 23(35):6012-22. PubMed ID: 15208679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced TSC2 RNA and protein in sporadic astrocytomas and ependymomas.
    Wienecke R; Guha A; Maize JC; Heideman RL; DeClue JE; Gutmann DH
    Ann Neurol; 1997 Aug; 42(2):230-5. PubMed ID: 9266734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome-based profiling of astrocytic tumours identifies prognostic gene expression signatures which link molecular and morphology-based pathology.
    Beetz C; Bergner S; Brodoehl S; Brodhun M; Ewald C; Kalff R; Krüger J; Patt S; Kiehntopf M; Deufel T
    Int J Oncol; 2006 Nov; 29(5):1183-91. PubMed ID: 17016650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of the tumor suppressor A-kinase anchor protein 12 in human diffuse and pilocytic astrocytomas is regulated by promoter methylation.
    Goeppert B; Schmidt CR; Geiselhart L; Dutruel C; Capper D; Renner M; Vogel MN; Zachskorn C; Zinke J; Campos B; Schmezer P; Popanda O; Wick W; Weller M; Meyermann R; Schittenhelm J; Harter PN; Simon P; Weichert W; Schirmacher P; Plass C; Mittelbronn M
    J Neuropathol Exp Neurol; 2013 Oct; 72(10):933-41. PubMed ID: 24042196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paired overexpression of ErbB3 and Sox10 in pilocytic astrocytoma.
    Addo-Yobo SO; Straessle J; Anwar A; Donson AM; Kleinschmidt-Demasters BK; Foreman NK
    J Neuropathol Exp Neurol; 2006 Aug; 65(8):769-75. PubMed ID: 16896310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel glioblastoma markers with diagnostic and prognostic value identified through transcriptome analysis.
    Reddy SP; Britto R; Vinnakota K; Aparna H; Sreepathi HK; Thota B; Kumari A; Shilpa BM; Vrinda M; Umesh S; Samuel C; Shetty M; Tandon A; Pandey P; Hegde S; Hegde AS; Balasubramaniam A; Chandramouli BA; Santosh V; Kondaiah P; Somasundaram K; Rao MR
    Clin Cancer Res; 2008 May; 14(10):2978-87. PubMed ID: 18483363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenascin expression in astrocytomas correlates with angiogenesis.
    Zagzag D; Friedlander DR; Miller DC; Dosik J; Cangiarella J; Kostianovsky M; Cohen H; Grumet M; Greco MA
    Cancer Res; 1995 Feb; 55(4):907-14. PubMed ID: 7531617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adult grade II diffuse astrocytomas are genetically distinct from and more aggressive than their paediatric counterparts.
    Jones DT; Mulholland SA; Pearson DM; Malley DS; Openshaw SW; Lambert SR; Liu L; Bäcklund LM; Ichimura K; Collins VP
    Acta Neuropathol; 2011 Jun; 121(6):753-61. PubMed ID: 21327941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization.
    Colin C; Baeza N; Bartoli C; Fina F; Eudes N; Nanni I; Martin PM; Ouafik L; Figarella-Branger D
    Oncogene; 2006 May; 25(19):2818-26. PubMed ID: 16314830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.